ES2200699A1 - Procedimiento para la separacion de r(-)- y s(+)-5-(2-((2-(2-etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida. - Google Patents

Procedimiento para la separacion de r(-)- y s(+)-5-(2-((2-(2-etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.

Info

Publication number
ES2200699A1
ES2200699A1 ES200201638A ES200201638A ES2200699A1 ES 2200699 A1 ES2200699 A1 ES 2200699A1 ES 200201638 A ES200201638 A ES 200201638A ES 200201638 A ES200201638 A ES 200201638A ES 2200699 A1 ES2200699 A1 ES 2200699A1
Authority
ES
Spain
Prior art keywords
ethoxyphenoxy
separating
enantiomers
methoxybenzene
sulphonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200201638A
Other languages
English (en)
Other versions
ES2200699B1 (es
Inventor
Fernandez Cristina Blanco
Guisasola Luis Octavio Silvia
Bonde-Larsen Antonio Lorente
Juarez Jorge Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ragactives SL
Original Assignee
Ragactives SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200201638A priority Critical patent/ES2200699B1/es
Application filed by Ragactives SL filed Critical Ragactives SL
Priority to EP03740513A priority patent/EP1522538A2/en
Priority to JP2004520689A priority patent/JP2005533094A/ja
Priority to CA002492270A priority patent/CA2492270A1/en
Priority to PCT/ES2003/000357 priority patent/WO2004006829A2/es
Priority to AU2003281155A priority patent/AU2003281155A1/en
Publication of ES2200699A1 publication Critical patent/ES2200699A1/es
Priority to US10/799,909 priority patent/US7105698B2/en
Application granted granted Critical
Publication of ES2200699B1 publication Critical patent/ES2200699B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C07C303/44—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/19—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para la separación de R(-)- y S(+)-5-[2-[[2-(2- etoxifenoxi)etil]amino)propil-2-metoxibenceno-sulfonamida. El procedimiento para separarlos enantiómeros R(-)- y S(+)-5-(2-((2- etoxifenoxi)etil)-amino)propil-2-metoxibencenosulfonamida comprende (a) hacer reaccionar una mezcla de dichos enantiómeros con un ácido orgánico ópticamente activo para formar sales diastereoisómeras con dichos enantiómeros, en donde dichas sales diastereoisómeras tienen distinta solubilidad y pueden ser separadas por cristalización; (b) separar la mezcla de sales diastereoisómeras enriquecida en la sal de uno de los enantiómeros; y (c) liberar dichas sales para obtener el enantiómero R(-)- o S(+)-. El enantiómero R(-)-5-(2-((2- etoxifenoxi)etil)-amino)propil-2-metoxibencenosulfonamida tiene actividad a-bloqueante adrenérgica y es útil como agente antihipertensor adecuado para el tratamiento de la insuficiencia cardiaca congestiva y la hipertrofia prostática benigna.
ES200201638A 2002-07-12 2002-07-12 Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida. Expired - Fee Related ES2200699B1 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ES200201638A ES2200699B1 (es) 2002-07-12 2002-07-12 Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
JP2004520689A JP2005533094A (ja) 2002-07-12 2003-07-11 Ｒ（−）−およびｓ（＋）−５−［２−［［２−（２−エトキシフェノキシ）エチル］アミノ］プロピル］−２−メトキシベンゼンスルホンアミドの分離方法
CA002492270A CA2492270A1 (en) 2002-07-12 2003-07-11 Method of separating r(-)- and s(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl-2-methoxybenzene-sulphonamide
PCT/ES2003/000357 WO2004006829A2 (es) 2002-07-12 2003-07-11 Procedimiento para la separación de r(-)- y s(+)-5-[2-[[2-(2-etoxifenoxi)etil]amino]propil-2-metoxibenceno-sulfonamida
EP03740513A EP1522538A2 (en) 2002-07-12 2003-07-11 Method of separating r(-)- and s(+)-5- 2- 2-(2-ethoxyphenoxy)ethyl]amino]propyl-2-methoxybenzene-sulphonamide
AU2003281155A AU2003281155A1 (en) 2002-07-12 2003-07-11 Method of separating r(-)- and s(+)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl-2-methoxybenzene-sulphonamide
US10/799,909 US7105698B2 (en) 2002-07-12 2004-03-12 Process for the separation of R(-)-and S(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2- methoxybenzenesulfonamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200201638A ES2200699B1 (es) 2002-07-12 2002-07-12 Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.

Publications (2)

Publication Number Publication Date
ES2200699A1 true ES2200699A1 (es) 2004-03-01
ES2200699B1 ES2200699B1 (es) 2005-10-01

Family

ID=30011364

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201638A Expired - Fee Related ES2200699B1 (es) 2002-07-12 2002-07-12 Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.

Country Status (7)

Country Link
US (1) US7105698B2 (es)
EP (1) EP1522538A2 (es)
JP (1) JP2005533094A (es)
AU (1) AU2003281155A1 (es)
CA (1) CA2492270A1 (es)
ES (1) ES2200699B1 (es)
WO (1) WO2004006829A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT103216B (pt) 2004-12-06 2010-05-19 Hovione Farmaciencia S A Preparação de tamsulosin
EP2161998B1 (en) * 2007-06-04 2015-09-02 Intra-Cellular Therapies, Inc. Pyridine derivatives as NET/SERT modulators
WO2010043571A1 (en) 2008-10-13 2010-04-22 Interquim, S.A. Process for the preparation of optically active (s)-(-)-2-(n-propylamino)-5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds
WO2012110092A1 (en) * 2011-02-17 2012-08-23 Synthon Bv Tamsulosin derivatives
US8792630B2 (en) * 2012-09-24 2014-07-29 Satmap International Holdings Limited Use of abstracted data in pattern matching system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2000382A6 (es) * 1985-11-13 1988-02-16 Yamanouchi Pharma Co Ltd Un procedimiento para la produccion de derivados de fenetilamina substituidos
ES2029838T3 (es) * 1986-07-21 1992-10-01 Yamanouchi Pharmaceutical Co. Ltd. Un procedimiento para producir un derivado de bencenosulfonamida opticamente activo.
US5447958A (en) * 1980-02-08 1995-09-05 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives, their preparation, and pharmaceutical compositions, containing them
WO2003037850A1 (en) * 2001-10-31 2003-05-08 Synthon B.V. Process for resolution of tamsulosin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
JPS57136561A (en) * 1981-02-17 1982-08-23 Yamanouchi Pharmaceut Co Ltd Benzenesulfonamide derivative
JP2696363B2 (ja) * 1988-02-19 1998-01-14 北陸製薬株式会社 フェノキシエチルアミン誘導体
CN1261411C (zh) 2001-10-31 2006-06-28 Dsmip资产有限公司 类视色素的制备

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447958A (en) * 1980-02-08 1995-09-05 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives, their preparation, and pharmaceutical compositions, containing them
ES2000382A6 (es) * 1985-11-13 1988-02-16 Yamanouchi Pharma Co Ltd Un procedimiento para la produccion de derivados de fenetilamina substituidos
ES2029838T3 (es) * 1986-07-21 1992-10-01 Yamanouchi Pharmaceutical Co. Ltd. Un procedimiento para producir un derivado de bencenosulfonamida opticamente activo.
WO2003037850A1 (en) * 2001-10-31 2003-05-08 Synthon B.V. Process for resolution of tamsulosin

Also Published As

Publication number Publication date
AU2003281155A1 (en) 2004-02-02
US20050004398A1 (en) 2005-01-06
JP2005533094A (ja) 2005-11-04
EP1522538A2 (en) 2005-04-13
WO2004006829A2 (es) 2004-01-22
WO2004006829A3 (es) 2004-04-08
AU2003281155A8 (en) 2004-02-02
US7105698B2 (en) 2006-09-12
ES2200699B1 (es) 2005-10-01
CA2492270A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
PA8645701A1 (es) Procedimiento para producir derivados de amina opticamente activos
BR0313070A (pt) Métodos para preparação de um diastereÈmero desejado de uma tetraidro-beta-carbolina e para preparação de um composto
EP2894227A3 (en) Process for preparing dipeptidyl peptidase iv inhibitors and intermediates therefor
PE20100232A1 (es) Procedimiento para preparar 8-(3-amino-piperidin-1-il)-xantinas quirales
NZ592827A (en) Methods of preparing quinoline derivatives
DE602005011609D1 (de) Verbessertes verfahren zur herstellung von 3-hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
TNSN05140A1 (en) Perindopril
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes
PE20040777A1 (es) Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina
DE60326341D1 (de) Verfahren zur herstellung von anthranilsäurederivat-hydrat
ATE422200T1 (de) Verfahren zur herstellung substituierter nikotinsäureester
ES2200699A1 (es) Procedimiento para la separacion de r(-)- y s(+)-5-(2-((2-(2-etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
BRPI0513881A (pt) processo para a preparação de compostos opticamente ativos
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
IT1319195B1 (it) Processo per la produzione dell'acido r(+)alfa-lipoico.
AU726662B2 (en) Solid compound, its preparation and use in medicine
ATE533758T1 (de) Verfahren zur herstellung von enantiomerenreinem esomeprazol
EP1634957A4 (en) 2-ALKYLCYSTEINAMIDE OR SALT, MANUFACTURING METHOD AND ITS USE
ATE299862T1 (de) Verfahren zur herstellung von ketiminen
ATE509619T1 (de) Herstellungsverfahren für eine feste dispersion mit itraconazol
WO2004032854A3 (en) Pharmaceutical compositions for treatment of parkinson's disease
DE602004006021D1 (de) Verfahren zur racematspaltung von nefopam
ATE548366T1 (de) Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040301

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2200699B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180808